Different multiple sclerosis (MS) prevalence rates were reported for Muslim and Christian Arabs in Israel. In this study, we evaluated whether associations of human leukocyte antigen (HLA) genes with MS may contribute to this prevalence difference. DNA samples from Israeli Arab MS patients (n ¼ 109) and controls (n ¼ 132) were typed for HLA class I (HLA-A, -B and -C) and II (HLA-DRB1 and -DQB1) genes. Global comparisons of HLA allele frequencies revealed significant differences between Christians and Muslims; therefore, case-control analyses were stratified by religious affiliation. Disease characteristics of Muslim and Christian Arab MS patients were similar to those reported for European populations. Opposing association signals with MS were observed for alleles composing the DRB1*0301-DQB1*0201 haplotype: positive association of the HLA-DRB1*0301 allele in Muslims (P Bonferroni ¼ 0.004, odds ratio (OR) ¼ 3.07), and negative association in Christian Arabs (P Bonferroni ¼ 0.01, OR ¼ 0.12), with similar results obtained for HLA-DQB1*0201. HLA-B*52 was negatively associated with MS only in Muslims (P Bonferroni ¼ 0.01, OR ¼ 0.03). The study presents for the first time a high-resolution HLA gene analysis in clinically well-characterized Arab populations with MS, and shows the population-specific contribution of the DRB1*0301-DQB1*0201 haplotype to disease susceptibility.
Introduction
Multiple sclerosis (MS) is a neurological disease with a strong inflammatory component. The precise etiology of MS remains unknown; however, both genetic and environmental factors presumably underlie disease pathogenesis. The major genetic effect has been attributed to the 6p major histocompatibility complex region, comprising the human leukocyte antigen (HLA) genes. 1, 2 Within this region, HLA class II genes such as HLA-DRB1 and HLA-DQB1 appear to be important in susceptibility and progression of disease, but a growing body of evidence is consistent with contributions beyond the HLA class II region, including effects from the nearby HLA class I genes HLA-A, -B and -C. [3] [4] [5] [6] Most genetic studies in MS focused, not surprisingly, on populations of Northern European descent, where prevalence of MS is relatively high. These studies have repeatedly affirmed the contribution of the HLA DR2 haplotype DQB1*0602-DQA1*0102-DRB1*1501-DRB5*0101 to disease risk; however, further dissection of the specific role of the genes within this haplotype has been limited by the high linkage disequilibrium structure prevalent in this chromosomal region. Recognition of this limitation has provoked studies in non-European populations, taking advantage of their different fine genomic architecture. For example, studies in African-American cohorts confirmed the contribution of DRB1*0301 and DRB1*1503 to MS risk, and the influence of HLA-DRB5 on disease progression. [7] [8] [9] In addition, studies on populations with unique MS prevalence patterns, or lower rates of the major susceptibility DR2 haplotype have revealed the full range of allelic heterogeneity at the DRB1 locus.
Epidemiology studies suggest a relation between MS prevalence and latitude, with risk increasing with distance from the equator. 10 However, specific enclaves of high or low risk have been reported in some populations, like Sardinia. 11 The presence of population-specific factors, including founder effects, particularly in immune-related genes, may modulate MS risk in different populations residing in the same geographical region. [12] [13] [14] [15] Middle East Arab populations have a range of MS prevalence in the low to medium rates. [16] [17] [18] [19] A recent epidemiological survey in Israel revealed that prevalence rates for Christian Arabs are thrice as high as for Muslim Arabs, suggesting that different risk factors operate in these two subethnic groups. 19 The Christian Arab population is a minority group among the Arab populations (B1.7% of the total population in Israel versus 16.6% for Muslim Arabs, according to the 2008 census, http://www1.cbs.gov.il/ shnaton59/st02_19.pdf). It has therefore been the subject of few genetic studies and little is known on its population structure. It is not clear whether these MS prevalence differences between Christians and other Israeli Arabs are the result of genetic differences, environmental effects or both. Because religion in the Middle East Arab population has shaped marriage practice over generations, it is likely that relatively high genetic homogeneity is present, which may be advantageous for genetic studies as it is expected to increase the statistical power. 20 Accordingly, two motives served as the driving force for this study: first, the advantage of genetic studies in non-European, inbred populations, where different linkage disequilibrium structure may lead to unmasking of new genetics factors for MS; and second, to provide clinical and epidemiological data on specific Arab populations for which there is relatively scarce information. Identification of distinct genetic profiles associated with MS may explain the different prevalence rates for MS in Muslims and Christian Arabs residing in Israel.
Results
Demographic data of the study participants and clinical characteristics are presented in Table 1 . The female/male ratio and the age of onset in the two patient populations (Muslim and Christian Arabs) were similar, as were the other clinical characteristics, including disease duration, and access to disease-modifying treatments. Many of the individuals serving as controls were the spouses of the patients. This enrollment strategy was chosen to increase similarity between cases and controls regarding domiciles and lifestyle factors; therefore gender ratio was significantly different between the case and control groups (Pp0.01). Case and control groups were well matched for age in both ethnic groups.
HLA allele frequencies in the Israeli Muslim and Christian Arab populations
Global comparisons of allele frequency distributions revealed significant differences between Christians and Muslims among the cases for HLA-DQB1, -DRB1, -B and -C (P ¼ 0.002, 0.001, 0.02 and 0.008), and for HLA-A in the control group (P ¼ 0.03) ( Table 2) ; therefore, case-control analyses were stratified by religious affiliation. Tables 3,  5 -7 present the allele frequencies for the five HLA loci studied. Deviation from Hardy-Weinberg equilibrium was not observed for any of the HLA gene alleles tested.
HLA class II analyses
Case-control analysis was significant for the HLA-DRB1 gene in both the Muslim and the Christian populations (Table 3 ; P ¼ 0.005 and 0.047, respectively). Further analysis indicated that in the Muslim population, DRB1*0301 is a major susceptibility allele, positively associated to MS (P B ¼ 0.004, odds ratio (OR) ¼ 3.07). Although the previously established risk allele DRB1*1501 was more frequent in the patient group, this difference did not attain statistical significance. Surprisingly, in the Christian Arab population the DRB1*0301 allele was negatively associated with MS (P B ¼ 0.012, OR ¼ 0.12). Moreover, DRB1*0301 homozygotes were observed only in the Christian control group (Table 4) . The DRB1*1501 allele was nominally associated with MS only in the Christian Arab group (P ¼ 0.033, OR ¼ 3.07); however, this association did not pass correction for multiple testing, likely due to the small cohort size. Testing for genotype association supports a significant effect for DRB1*0301 genotypes in both Muslims and Christian Arabs (P ¼ 0.002 and 0.02, respectively). Analysis of the DQB1 locus revealed a significant difference between cases and controls in the Muslim (P ¼ 0.0002), and trend for the Christian population (P ¼ 0.065) ( Table 5 ). The DQB1*0201 allele, which is part of the known DRB1*0301-DQB1*0201 haplotype, was, as expected, associated with the disease in both ethnicities although in different directions. In Muslims, a nominal association was observed also for the DQB1*0501 (P ¼ 0.013, OR ¼ 2.81). Haplotype analysis indicated that the DQB1*0501 allele was present on several haplotypes with different HLA-DRB1 alleles (Table 8) ; however, the small sample size of this study precludes any definitive conclusions regarding the role of this allele and its associated haplotypes.
After adjusting for gender effect as a confounding variable, logistic regression modeling supported a major genetic effect from the DRB1*0301 in both the Muslim (P ¼ 0.0008, OR ¼ 3.17) and the Christian Arab (P ¼ 0.004, OR ¼ 0.10) cohorts, with exclusion of the DQB1*0201 allele from the model as a dependent variable. The allelic logistic association was significant for the DQB1*0501 allele (P ¼ 0.03) as well in the Muslim cohort.
The contradictory association signal observed in Muslim and Christian Arabs for the DRB1*0301-DQB1*0201 haplotype might be due to a genetic difference within or beyond the HLA region. We therefore analyzed 21 single nucleotide polymorphisms (SNPs) across the major histocompatibility complex region in a subgroup of cases and controls of both Others include the following HLA-C alleles that were less than 5% frequent-Muslims: HLA-C*-01, 02, 05, 08, 14 and 18; Christians: HLA-C*-01, 02, 05 and 14.
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G Benedek et al subethnicities and imputed parental haplotypes. For the DRB1*0301-DQB1*0201 haplotype, a highly conserved and specific 10-SNP haplotype was present across the HLA-DRB1 and -DQB1 gene regions (Figure 1 ), in both Muslim and Christian Arab individuals, suggesting their genetic background across this locus is similar and cannot therefore account for the opposing associations observed. The SNP haplotype was specifically associated with DRB1*0301-DQB1*0201, as it was present in our data set only once (out of 51 chromosomes) on the background of another DRB1-DQB1 haplotype. The conservation between Muslim and Christian Arab SNP haplotypes was not a general phenomenon, as DRB1*1501-associated haplotypes showed higher heterogeneity.
HLA class I analyses
Global case-control analysis for HLA class I genes (HLA-A, -B, -C; Tables 6 and 7 ) was significant only for HLA-B locus in the Muslim population (global P ¼ 0.009). The HLA-B*52 allele remained significant after correcting for multiple testing, was negatively associated with MS (P B ¼ 0.01, OR ¼ 0.03) and totally absent from the patient population. HLA-B*52 also emerged as an independent factor from gender and other HLA class II alleles in logistic regression modeling (P ¼ 0.04).
Discussion
In this study, we investigated the associations between HLA class I and class II genes and MS in the Israeli Arab population, and for the first time present allele frequency data for the Christian Arab population. The HLA region, and particularly the class II HLA-DRB1 gene locus, has been shown in numerous studies to be associated with MS susceptibility. The results of this study confirm the genetic effect of this region in Israeli Arab populations, while highlighting the complex contributions of the HLA-DRB1*0301 allele and its extended haplotype.
Religious affiliation was used as a proxy for population classification. This decision was prompted by the observation of different rates of MS in Muslim and Christian Israeli Arabs. 19 Moreover, although Christianity and Islam have coexisted for many centuries in the Middle East, religion has effectively been a barrier to population admixture. Genetic studies reporting a strong effect for religion on Y-chromosome marker distributions in the neighboring Lebanese population, 21 and the different allele frequency distribution observed herein for five HLA class I and class II genes, support analyzing the data stratified by religion. It is of interest that allele frequency differences were observed mainly between case groups, suggesting that different genetic factors, govern, at least in part, disease risk in the two religion groups.
Clinical characteristics of patient cohorts
The Muslim and Christian Arab patient cohorts in this study appear to share similar demographics and disease characteristics. Clinical characteristics were similar to that described in European populations, 22 AfricanAmerican populations 23, 24 as well as other Arab populations. [16] [17] [18] 25, 26 At the time of recruitment, only a minority of the patients was at an advanced stage of disease. This may reflect the relative young age of the cohorts, the modification of the natural history of the disease by the immunomodulatory treatments, as well as an inherent recruitment bias for less disabled MS individuals, capable of attending the MS clinics and cognitively capable of informed consent. Primary progressive course of disease rates are lower than reported for populations of European descent (B15%), 22, 24 but similar to rates reported in other Arab populations (3.6-7.9%). [16] [17] [18] However, the small cohort size and the recruitment bias may account for the low primary progressive rates.
Allele distribution of HLA genes in Israeli Arabs
Comparison of the HLA data in the control populations of this study with published data from other Arab cohorts, as well as Y chromosome genetic studies, emphasizes the presence of regional population stratification. [27] [28] [29] [30] These observations highlight the importance of procuring a locality-and religion-based set of matched controls for association studies in Arab populations, as was carried out for this study.
The few studies available on classical HLA genes in MS patients of Arab descent are based on serological testing. [31] [32] [33] [34] These studies report association of the DR2 allelic family (that includes also the DRB1*15 allele group) and DR3 with MS. Thus, this study is the first to provide detailed high-resolution data for the HLA-A, -B, -C, DRB1 and -DQB1 allele distribution in Christian Arabs and association with MS risk in populations of Arab descent.
DRB1*0301-DQB1*0201 haplotype and MS risk in Israeli Arabs
The most interesting result of this study is the opposite associations for the DRB1*0301-DQB1*0201 haplotype in Muslim versus Christian Arabs as deduced from the DRB1*0301 and DQB1*0201 allelic tests. The increased MS risk associated with this haplotype has been previously reported in both populations at high and low risk for MS. 7, 12, 35, 36 This is the first report that may
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97% (36) 3% (1) 93% (14) 7% (1) 75% (9) 17% (2) 8% (1) 53% (8) 47% (7) Genetics of multiple sclerosis in Israeli Arabs G Benedek et al indicate a 'protective' effect for the same haplotype, in a population previously unstudied, the Christian Arabs. A similar phenomenon was reported for DRB1*07, which is negatively associated with type I diabetes (T1D) in Yemenite Jews and a few other populations, but is positively associated with type I diabetes in African blacks. 37 Studies in humanized mouse harboring transgenic DRB1*0301 suggest that for this allele genetic interactions in trans have a major role in determining disease outcome in the experimental autoimmune encephalitis model. Thus, presence of DQB1*0601 protected the mice from experimental autoimmune encephalitis whereas presence of DQB1*0302 led to higher disease incidence and severity. 38, 39 The embedded SNP haplotype for the DRB1*0301-DQB1*0201 appeared to be conserved across Muslim and Christian individuals, implying that its contrasting genetic effects may result from a modifier outside the class II region, exerting epistasis effects. Although Muslim and Christian Arabs in Israel share a similar geographical environment, it should be noted that lifestyle differences are present (including dietary differences, for example, as dictated by religion, family size and so on), which may also confer a modifying effect through gene-environment interactions. 40 Alternatively, low frequency or rare genetic polymorphisms within the DRB1*0301-DQB1*0201 haplotype block, which are not captured by the SNPs studied herein, remain a possibility.
The negative association of the DRB1*0301 haplotype with MS in Christian Arabs is based on its low frequency among recruited cases. It is unlikely that this observation was derived from inclusion of related individuals in the data set, as our recruitment strategy included meticulous assessment of possible relatedness between participants through assessment of surnames and clans. Moreover, the participants of the control group were recruited, where possible, from the same localities as the cases, to ensure a similar representation of the regional genetic background. Therefore, the observed lower frequency of the DRB1*0301 haplotype in affected Christian Arabs is likely to be a true observation.
Other HLA gene associations and MS susceptibility in the Israeli Arab populations DRB1*1501 is considered the HLA allele with the strongest genetic effect known on MS. 1 The frequency of the DRB1*1501 allele in the Israeli Arab population is low, limiting the power of the study to detect effects of this allele. Accordingly, although the DRB1*1501 was more frequent among cases, nominal significance was observed only in the Christian cohort.
Haplotype analysis based on family data, homozygotes and inference suggests that in Israeli Arabs, in addition to the European haplotype DRB1*1501-DQB1*0602, the DRB1*1501 is present also on haplotypes in linkage with DQB1*0501 and others (Table 8 ). This suggests the haplotype structure in Israeli Arab populations differs from that prevalent in Europe, confirming their advantage for genetic studies of the HLA genes in MS.
The HLA-B*52-negative association we observed in the Muslim cohort is a new observation that remains to be further validated. This finding is even more interesting in light of the recent suggestion for a protective role in MS for the HLA-Bw4 serological group, as the HLA-B*52 carries this serological specificity, 41 possibly relating to HLA-Bw4 function as a ligand for the killer immunoglobulin-like receptors. Notably, HLA-B*52 is more prevalent in world regions with low MS prevalence such as Japan, 10, 42 where its frequency was reported as lower in MS patients, although not statistically significant. 43 
Conclusions
This study confirms the importance of the HLA-DRB1 gene for MS susceptibility in Arab populations, and provides data on MS in the Christian Arab population for the first time. By using religion as a population classifier, we were able to show significant though contrasting effects for the DRB1*0301-DQB1*0201 haplotype in these populations. Therefore, the overall effect of the DRB1*0301-DQB1*0201 haplotype on MS risk is likely determined through interactions with additional genetic and environmental factors. Future studies on these Arab populations in Israel, the neighboring countries and immigration countries with congregations of these populations, such as the United States, will allow expansion of these findings on genetic effects of the HLA genes, and possibly others, to MS susceptibility and disease course. Inference from all carriers of the DRB1*1501 allele. Identity of allele in linkage could not be determined due to small sample size.
Materials and methods
Study participants
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Christians and 90 Muslims) healthy controls were included in the final analysis. On the basis of our earlier epidemiological survey, 19 we estimate this cohort to represent about 60% of the Muslim Israeli Arab MS patients and 70% of the Christian Arab patients. The study protocol received ethical approval from the Israeli Ministry of Health Helsinki Committee for Genetics Studies. All participants signed an informed consent.
Unrelated controls were enrolled mainly from spouses and friends of patients, with emphasis on matching residence where possible; exclusion criteria included presence of MS in family members up to third degree, or presence of any autoimmune or chronic inflammatory condition. Individuals were included in the genetic analysis only if all four grandparents were of the same subethnic affiliation to minimize stratification effects.
Detailed demographic and clinical data were obtained from all subjects. MS disease type (relapsing-remitting, secondary-progressive, relapsing-progressive or primary-progressive) and Expanded Disability Status Scale (EDSS 46 ) score were recorded at date of clinical report. DNA was extracted from blood samples using standard procedures (Puregene, Gentra Systems, Minneapolis, MN, USA), or from saliva samples using the Oragene DNA kit (DNA-Genotek, Ottawa, Ontario, Canada).
HLA typing HLA-DRB1, -DQB1, -A and -B loci at low resolution were typed using the Lipa HLA kit (Murex Innogenetics, Ghent, Belgium).
High-resolution typing of the HLA-DRB1*03, *11, *13 and *15 alleles used the PCR sequence-specific primer method (Olerup kit, Saltsjobaden, Sweden). High-resolution typing of the remaining alleles was performed with the Lipa HLA-DRB decoder kit (Murex Innogenetics, Gent, Belgium).
HLA-C was typed using the LIFECODES HLA-C typing kit (Tepnel, Lifecodes, Stamford, CT, USA). The samples were analyzed with the Luminex 100 system (Luminex, Austin, TX, USA). Genotyping was performed masked to the status of the sample.
All samples were successfully genotyped except for one sample that failed HLA-B typing. Available family members were typed for haplotype reconstruction, as well as to check for Mendelian inconsistencies.
SNP genotyping
Illumina GoldenGate MHC mapping panel GT-17-180 SNP data (1293 SNPs) were available for 68% of the Muslim and 91% of the Christian data sets. Data filtering removed samples and SNPs with success rate o95%. Owing to small cohort sizes, stringent criteria were used excluding SNPs with minor allele frequency o10%; or Hardy-Weinberg equilibrium test at Pp0.01. The final number of SNPs available for analysis was 937. Twentyone SNPs (rs2524005, rs2860580, rs3094141, rs2853961, rs4361609, rs3873386, rs2156875, rs2523586, rs2523567, rs2844580, rs2844575, rs2253908, rs5020946, rs660895, rs7451962, rs6931337, rs3129763, rs9272346, rs9272535, rs9272723 and rs3891175) were manually selected to span the HLA class I and class II regions, taking into account inter-or intragenic location and relative spacing between SNPs. The final data set included 52 affected and 54 controls in the Muslim cohort; 40 affected and 37 controls from the Christian cohort.
Statistical analysis
Statistical analysis of clinical and demographic data was conducted using SPSS version 15.0 (SPSS Inc., Chicago, IL, USA). Categorical variables were compared using w 2 -test. Continuous variables were tested for normality by the nonparametric one sample Kolmogorov-Smirnov test, and then compared using t-tests or Mann-Whitney tests, as appropriate.
Allelic frequencies of the HLA-DRB1, -DQB1, HLA-A, HLA-B and HLA-C genes were compared using SPSS version 15.0 and JMP-Genomics version 3.2 software applications (Cary, NC, USA). Global w 2 -tests and exact tests using Monte Carlo repeated sampling methods (10 000 sampled tables) were used to compare allele distributions between Muslims and Christians for each HLA gene in case and control groups. Case-control comparisons were then performed within each ethnic group using the Pearson's w 2 -test or exact tests using Monte Carlo methods as appropriate, if a cell with a count of less than 5 was present. Rare alleles with a frequency of o5% in both cases and controls groups were pooled. For specific alleles 2 Â 2 Pearson's w 2 -test or Fisher's exact test were computed. P-values lower than 0.05 were considered statistically significant after applying the Bonferroni correction (P B ). The OR and 95% CI were calculated for statistically significant alleles, using asymptotic confidence limits, or exact confidence limits when Fisher's exact test was used, or the 'median unbiased estimation' for OR and CI when empty cells were present. 47 Deviation from Hardy-Weinberg equilibrium was tested in controls, for each allele versus all other alleles as a pool. Genotype association test was applied for the DRB1*0301 allele, implementing the exact Monte Carlo estimation for the P-value (10 000 repeated samplings) to account for the small sample size available. A forward stepwise conditional logistic regression analysis was performed with possible confounding variables, such as gender, in the model. The criteria for stepwise selection were set at entrance P-value p0.05 and removal P-value X0.15. All P-values reported (Wald test) are two sided. SNP haplotypes were inferred using the EM algorithms as implemented in JMP Genomics, only inferred haplotypes with a probability of 1 were accepted. HLA haplotypes were inferred, where possible, by using family data or as derived from homozygote data. 
